Table 3.
Observations | Group-I (Mean ± SD) | Group-II (Mean ± SD) | p Values | Percentage Difference (%) |
---|---|---|---|---|
Age (years) | 42.10 ± 8.22 | 46.20 ± 5.97 | 0.079 | 9.29 |
Fasting blood glucose level (mg/dL) | 116.30 ± 6.09 | 145.45 ± 6.14 * | 0.001 | 22.27 |
HbA1c (%) | 5.68 ± 0.22 | 6.74 ± 0.17 * | 0.001 | 17.07 |
PI | 1.32 ± 0.40 | 1.46 ± 0.52 * | 0.05 | 10.07 |
GI | 1.24 ± 0.36 | 1.56 ± 0.56 * | 0.05 | 22.86 |
PPD (mm) | 2.69 ± 0.36 | 2.77 ± 0.65 * | 0.05 | 2.93 |
CAL (mm) | 3.02 ± 0.68 | 3.11 ± 0.68 * | 0.05 | 2.94 |
IL-17 (pg/mL) | 0.18 ± 0.03 | 0.21 ± 0.04 * | 0.01 * | 16.21 |
* p < 0.05 significant compared between the group-I with group-II before treatment.